PMC6079597_01
Echocardiogram imaging of a globular mass attached to the mitral valve of heterogeneous echogenicity.
CRIC2018-3927948.001.jpg
PMC6079597_01_CRIC2018-3927948.001.jpg
fig1
A transesophageal echocardiogram done to better delineate the consistency of the lesion revealed a 10 x 7 mm noncalcified mass with uniform echodensity located on the atrial side of P2 (Figures 1 and 2).
Echocardiogram imaging of a globular mass attached to the mitral valve of heterogeneous echogenicity.
CRIC2018-3927948.002.jpg
PMC6079597_01_CRIC2018-3927948.002.jpg
fig2
A transesophageal echocardiogram done to better delineate the consistency of the lesion revealed a 10 x 7 mm noncalcified mass with uniform echodensity located on the atrial side of P2 (Figures 1 and 2).
Gross pathology of the 9.0 x 8.0 x 6.0 mm myxoma.
CRIC2018-3927948.003.jpg
PMC6079597_01_CRIC2018-3927948.003.jpg
fig3
Histopathological findings confirmed a 9.0 x 8.0 x 6.0 mm myxoma (Figure 3) attached to the external valve leaflet.
Presence of stellate cells in the background of a myxoid substance.
CRIC2018-3927948.004.jpg
PMC6079597_01_CRIC2018-3927948.004.jpg
fig4
The tumor was composed of stellate cells with eosinophilic cytoplasm, indistinct boarders, oval nucleus with open chromatin, and indistinct nuclei in the background of a myxoid substance (Figures 4 and 5).
Red arrow identifying the presence of stellate cells.
CRIC2018-3927948.005.jpg
PMC6079597_01_CRIC2018-3927948.005.jpg
fig5
The tumor was composed of stellate cells with eosinophilic cytoplasm, indistinct boarders, oval nucleus with open chromatin, and indistinct nuclei in the background of a myxoid substance (Figures 4 and 5).